The aims of this study were to 1) develop a detection model for recognizing panic disorder (PD), 2) develop a simple questionnaire as a screening instrument for PD detection, and 3) test in an outpatient cardiological chest pain population a detection model for panic disorder previously described by Fleet et al. [20]. Logistic regression analysis was performed to explore factors predictive of panic disorder and to test the cross-cardiological setting constancy of the Fleet model in 199 chest pain patients without previously known heart disease referred to cardiological outpatient investigation of chest pain. The SCL-90 somatization subscale, Agoraphobia Cognitions Questionnaire, chest pain quality, pain localization, and age were the best predictors of the presence of panic disorder. This model correctly classified 78% of the subjects. The sum-score of a three-item questionnaire correctly classified 74% of the subjects, while the previously described model by Fleet et al. correctly classified 73% of the subjects. A detection model and a screening questionnaire are proposed to improve the recognition of PD in this chest pain population. This study partly supports the cross-setting validity of a previously described detection model.

Adult↗

PubMedDate not supplied

Personality profiles in patients referred for chest pain. Investigation with emphasis on panic disorder patients.

Patients (N = 199) referred to cardiac outpatient investigation because of chest pain were assessed with the Personality Diagnostic Questionnaire (PDQ-4). Thirty-nine percent scored positive for any personality disorder. Borderline and avoidant personality disorders were found significantly more often in patients with panic disorder (PD) (n = 72) than in patients without PD (12.5% vs. 2.5%, 23.7% vs. 7.7%, respectively). In PD patients, the presence of any personality disorder was significantly associated with higher scores of self-reported anxiety-agoraphobia symptoms, neuroticism, and the presence of suicidal thoughts. These results suggest that personality pathology is important in a subgroup of patients presenting with chest pain and that these patients may require more extensive treatment.

Adolescent↗

PubMedDate not supplied

Effects of highly concentrated omega-3 polyunsaturated fatty acids and acetylsalicylic acid, alone and combined, on bleeding time and serum lipid profile.

Twenty-two patients with stable coronary heart disease were randomly assigned to either of two groups. Group I (n = 11) was given acetylsalicylic acid (ASA) 300 mg daily for 1 week, whereafter a daily supplement of 3,4 g eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) as a highly concentrated ethylester, formulation ("K-85", Norsk Hydro) was added for another 4 weeks. Group II (n = 11) was given 3,4 g daily of EPA and DHA for 4 weeks, after which ASA 300 mg daily was added for another week. Determination of serum fatty acids confirmed satisfying absorption of EPA and DHA. A significant increase of the Ivy bleeding time was registered following administration of both "K-85" (240 to 270 sec, median values) and ASA (270 to 360 sec, median values) alone. A slighter increase was noted by a combination of the two principles. A reduction in serum triglycerides of 17% was noted after "K-85" (median values, both groups). Serum total cholesterol decreased after "K-85" administration in group I, but not so in group II. HDL-cholesterol remained unchanged. Serum lipids remained unaffected by ASA. During administration of "K-85" no adverse effects or bleeding episodes were seen.

Adult↗

PubMedDate not supplied

Primary ventricular fibrillation complicating acute myocardial infarction: incidence in subgroups.

Explore the source record for details and available documents.

Aged↗